For many people, the thought of a tasty burger or a cold pint of beer conjures up a vivid mental image and drives behaviour. This link between thinking and doing serves a clear function – it motivates ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...

There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are prescribed for weight loss, diabetes, and blood-sugar management. But as more people use them, patients are reporting a decrease in cravings for ...

Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...